RACHEL ECKERT: Open Payments
NPI 1942880315 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,475 in 174 payments from 26 companies in 2025. Trend: 2023 $1,064 · 2024 $5,671 · 2025 $5,475
Food & beverage: $5,461Education: $13
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 31 | $928 |
| Galderma Laboratories, L.P. | 19 | $860 |
| ABBVIE INC. | 19 | $714 |
| Janssen Biotech, Inc. | 25 | $558 |
| GENZYME CORPORATION | 10 | $370 |
| Novartis Pharmaceuticals Corporation | 16 | $340 |
| Incyte Corporation | 10 | $276 |
| Regeneron Healthcare Solutions, Inc. | 5 | $190 |
| Organon LLC | 7 | $186 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $165 |
Products named: Bimzelx, TREMFYA, NEMLUVIO, SKYRIZI, DUPIXENT, OPZELURA, COSENTYX, Zoryve.
Industry payments across TN — which companies pay providers there.
